Microbiota in patients with cefuroxime resistance and anal fistula revealed by 16S ribosomal DNA
This study suggests that specific gut microbiota, particularly <i>Butyricicoccus</i> and <i>Roseburia</i>, may mitigate cefuroxime resistance in anal fistula patients by increasing butyrate production. Probiotic intervention targeting gut microbiota composition presents a promising strategy for reducing antibiotic resistance and improving clinical outcomes.
Authors
- B Li
- S Zhong (ORCID: https://orcid.org/0000-0003-4209-4933)
- Baishi Hu (ORCID: https://orcid.org/0000-0001-6992-2239)
- Fei Yao (ORCID: https://orcid.org/0000-0001-8414-7955)
- Chenxi Cao (ORCID: https://orcid.org/0000-0002-6668-4164)
- Zhenwei Chen (ORCID: https://orcid.org/0000-0002-5798-5686)
- Guanglei Hu (ORCID: https://orcid.org/0000-0001-8169-6182)
- Shanshan Li (ORCID: https://orcid.org/0000-0001-5745-7835)
- Jiahua Li (ORCID: https://orcid.org/0000-0001-7597-8829)
- Yun Ling (ORCID: https://orcid.org/0000-0003-2423-1965)
- Min Qiu (ORCID: https://orcid.org/0000-0003-0508-0735)
Institutions
- Jiaxing University (CN)
- First Hospital of Jiaxing (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Surgery
- Published
- 2024-12-27
- DOI
- https://doi.org/10.4240/wjgs.v17.i1.100790
- Primary Topic
- Anorectal Disease Treatments and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiaxing University